
CAS 199192-04-6: 1H-Imidazole-4-carboxaldehyde,1-propyl-(9CI)
Description:1H-Imidazole-4-carboxaldehyde, 1-propyl- (CAS 199192-04-6) is a chemical compound characterized by its imidazole ring, which is a five-membered heterocyclic structure containing two nitrogen atoms. This compound features a carboxaldehyde functional group (-CHO) at the 4-position of the imidazole ring and a propyl group attached to the nitrogen at the 1-position. It is typically a colorless to pale yellow liquid or solid, depending on its state at room temperature. The presence of the aldehyde group suggests it can participate in various chemical reactions, such as condensation and oxidation. Its imidazole structure contributes to its potential biological activity, making it of interest in medicinal chemistry and research. The compound is soluble in polar solvents, which is common for imidazole derivatives, and may exhibit properties such as antimicrobial or antifungal activity, although specific biological activities would require further investigation. Safety data should be consulted for handling and usage, as with any chemical substance.
Formula:C7H10N2O
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | 1H-Imidazole-4-carboxaldehyde, 1-propyl- REF: IN-DA002BYJCAS: 199192-04-6 | - - - | To inquire | Thu 27 Mar 25 |
![]() | 1-Propyl-1H-imidazole-4-carbaldehyde REF: 10-F638025CAS: 199192-04-6 | 97% | - - - | Discontinued product |
![]() | 1-Propyl-1H-imidazole-4-carbaldehyde REF: 3D-ZHA19204CAS: 199192-04-6 | Min. 95% | - - - | Discontinued product |

Ref: IN-DA002BYJ
Undefined size | To inquire |

Ref: 10-F638025
1g | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information |

1-Propyl-1H-imidazole-4-carbaldehyde
Ref: 3D-ZHA19204
1g | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |